Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Mobile Health Technologies May Be Acceptable Tools for Providing Social Support to Tuberculosis Patients in Rural Uganda: A Parallel Mixed-Method Study.

Musiimenta A, Tumuhimbise W, Atukunda EC, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D, Davis JL, Haberer JE.

Tuberc Res Treat. 2020 Jan 7;2020:7401045. doi: 10.1155/2020/7401045. eCollection 2020.

2.

Experience with antiretroviral electronic adherence monitoring among young African American men who have sex with men living with HIV: findings to inform a triaged real-time alert intervention.

Dworkin MS, Panchal P, Wiebel W, Garofalo R, Jimenez A, Haberer JE.

AIDS Care. 2020 Jan 15:1-10. doi: 10.1080/09540121.2020.1713975. [Epub ahead of print]

PMID:
31941360
3.

Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa.

Wanga V, Baeten JM, Bukusi EA, Mugo NR, Asiimwe S, Ngure K, Mujugira A, Muwonge T, Odoyo JB, Haberer JE, Celum C, Heffron R; Partners Demonstration Project Team.

AIDS Behav. 2020 Jan 10. doi: 10.1007/s10461-019-02773-5. [Epub ahead of print]

PMID:
31925607
4.

Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?

Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre J, Moodley D, Mofenson LM, Mugo N, Myer L, Mujugira A, Shoptaw S, Stranix-Chibanda L, John-Stewart G; PrEP in Pregnancy Working Group.

J Int AIDS Soc. 2020 Jan;23(1):e25426. doi: 10.1002/jia2.25426. Review.

5.

Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study.

Musiimenta A, Tumuhimbise W, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D, Davis JL, Haberer JE.

J Clin Tuberc Other Mycobact Dis. 2019 Aug 29;17:100119. doi: 10.1016/j.jctube.2019.100119. eCollection 2019 Dec.

6.

Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.

Mugendi AG, Kubo MN, Nyamu DG, Mwaniki LM, Wahome SK, Haberer JE.

Neurol Res Int. 2019 Oct 30;2019:5173289. doi: 10.1155/2019/5173289. eCollection 2019.

7.

The meaning of "rapid" antiretroviral therapy initiation for adolescents with HIV in sub-Saharan Africa.

Zanoni BC, Haberer JE.

J Infect Dis. 2019 Nov 4. pii: jiz548. doi: 10.1093/infdis/jiz548. [Epub ahead of print] No abstract available.

PMID:
31682259
8.

Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression.

Musinguzi N, Castillo-Mancilla J, Morrow M, Byakwaga H, Mawhinney S, Burdo TH, Boum Y, Muzoora C, Bwana BM, Siedner MJ, Martin JN, Hunt PW, Bangsberg DR, Haberer JE.

J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):386-391. doi: 10.1097/QAI.0000000000002148.

PMID:
31658181
9.

Knowledge of HIV Status Is Associated With a Decrease in the Severity of Depressive Symptoms Among Female Sex Workers in Uganda and Zambia.

Ortblad KF, Musoke DK, Chanda MM, Ngabirano T, Velloza J, Haberer JE, McConnell M, Oldenburg CE, Bärnighausen T.

J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):37-46. doi: 10.1097/QAI.0000000000002224.

10.

PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.

Gilbert HN, Wyatt MA, Pisarski EE, Muwonge TR, Heffron R, Katabira ET, Celum CL, Baeten JM, Haberer JE, Ware NC.

J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):265-274. doi: 10.1097/QAI.0000000000002139.

PMID:
31609925
11.

High Rates of Biomarker-Confirmed Alcohol Use Among Pregnant Women Living With HIV in South Africa and Uganda.

Raggio GA, Psaros C, Fatch R, Goodman G, Matthews LT, Magidson JF, Amanyire G, Cross A, Asiimwe S, Hahn JA, Haberer JE.

J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):443-451. doi: 10.1097/QAI.0000000000002156.

12.

Global implementation of PrEP for HIV prevention: setting expectations for impact.

Pyra MN, Haberer JE, Hasen N, Reed J, Mugo NR, Baeten JM.

J Int AIDS Soc. 2019 Aug;22(8):e25370. doi: 10.1002/jia2.25370.

13.

Home-based tuberculosis contact investigation in Uganda: a household randomised trial.

Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, Mark D, Babirye D, Okello DA, Mugabe F, Fair E, Vittinghoff E, Armstrong-Hough M, Dowdy D, Cattamanchi A, Haberer JE, Katamba A.

ERJ Open Res. 2019 Jul 29;5(3). pii: 00112-2019. doi: 10.1183/23120541.00112-2019. eCollection 2019 Jul.

14.

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach.

Mallayasamy S, Chaturvedula A, Fossler MJ, Sale ME, Hendrix CW, Haberer JE.

Front Pharmacol. 2019 Jul 12;10:785. doi: 10.3389/fphar.2019.00785. eCollection 2019.

15.

Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.

Matthews LT, Jaggernath M, Kriel Y, Smith PM, O'Neil K, Haberer JE, Hendrix C, Baeten JM, Ware NC, Wirth K, Psaros C, Bangsberg DR, Smit JA.

BMJ Open. 2019 Jul 26;9(7):e027227. doi: 10.1136/bmjopen-2018-027227.

16.

Is knowledge of HIV status associated with sexual behaviours? A fixed effects analysis of a female sex worker cohort in urban Uganda.

Ortblad KF, Musoke DK, Ngabirano T, Salomon JA, Haberer JE, McConnell M, Oldenburg CE, Bärnighausen T.

J Int AIDS Soc. 2019 Jul;22(7):e25336. doi: 10.1002/jia2.25336.

17.

Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda.

Siedner MJ, Bwana MB, Asiimwe S, Musinguzi N, Castillo-Mancilla J, Amanyire G, Tracy RP, Bangsberg DR, Orrell C, Haberer JE; META Study Investigators.

AIDS. 2019 Nov 1;33(13):2043-2048. doi: 10.1097/QAD.0000000000002305.

18.

HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.

Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, Donnell D, Mugo NR, Baeten JM, Ngure K.

Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.

19.

Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study.

Siedner MJ, Bwana MB, Asiimwe S, Amanyire G, Musinguzi N, Castillo-Mancilla J, Tracy RP, Katz IT, Bangsberg DR, Hunt PW, Orrell C, Haberer JE; META study investigators .

J Infect Dis. 2019 Aug 30;220(7):1172-1177. doi: 10.1093/infdis/jiz259.

20.

Tenofovir Plasma Concentration from Preexposure Prophylaxis at the Time of Potential HIV Exposure: a Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa.

Mallayasamy S, Chaturvedula A, Fossler MJ, Sale M, Goti V, Bumpus NN, Marzinke MA, Hendrix CW, Haberer JE; Partners Demonstration Project Team.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00446-19. doi: 10.1128/AAC.00446-19. Print 2019 Aug.

21.

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women.

Pyra M, Anderson P, Haberer JE, Heffron R, Celum C, Asiimwe S, Katabira E, Mugo NR, Bukusi EA, Baeten JM.

Front Pharmacol. 2019 Apr 17;10:401. doi: 10.3389/fphar.2019.00401. eCollection 2019.

22.

High Incidence of Intended Partner Pregnancy Among Men Living With HIV in Rural Uganda: Implications for Safer Conception Services.

Kaida A, Kabakyenga J, Bwana M, Bajunirwe F, Muyindike W, Bennett K, Kembabazi A, Haberer JE, Boum Y, Martin JN, Hunt PW, Bangsberg DR, Matthews LT.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):497-507. doi: 10.1097/QAI.0000000000002053.

PMID:
30973545
23.

A triaged real-time alert intervention to improve antiretroviral therapy adherence among young African American men who have sex with men living with HIV: focus group findings.

Dworkin MS, Panchal P, Wiebel W, Garofalo R, Haberer JE, Jimenez A.

BMC Public Health. 2019 Apr 11;19(1):394. doi: 10.1186/s12889-019-6689-1.

24.

Proactive text messaging (GetReady2Quit) and nicotine replacement therapy to promote smoking cessation among smokers in primary care: A pilot randomized trial protocol.

Kruse GR, Park E, Haberer JE, Abroms L, Shahid NN, Howard SE, Chang Y, Haas JS, Rigotti NA.

Contemp Clin Trials. 2019 May;80:48-54. doi: 10.1016/j.cct.2019.03.006. Epub 2019 Mar 25.

PMID:
30923022
25.

Combining Real-Time Ratings With Qualitative Interviews to Develop a Smoking Cessation Text Messaging Program for Primary Care Patients.

Kruse G, Park ER, Shahid NN, Abroms L, Haberer JE, Rigotti NA.

JMIR Mhealth Uhealth. 2019 Mar 26;7(3):e11498. doi: 10.2196/11498.

26.

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa.

Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker LG.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958219831011. doi: 10.1177/2325958219831011.

27.

ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa.

Haberer JE, Bwana BM, Orrell C, Asiimwe S, Amanyire G, Musinguzi N, Siedner MJ, Matthews LT, Tsai AC, Katz IT, Bell K, Kembabazi A, Mugisha S, Kibirige V, Cross A, Kelly N, Hedt-Gauthier B, Bangsberg DR.

J Int AIDS Soc. 2019 Feb;22(2):e25232. doi: 10.1002/jia2.25232.

28.

The Effect of HIV Self-Testing Delivery Models on Female Sex Workers' Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda.

Ortblad KF, Kibuuka Musoke D, Ngabirano T, Nakitende A, Harling G, Haberer JE, McConnell M, Salomon JA, Oldenburg CE, Bärnighausen T.

AIDS Behav. 2019 May;23(5):1225-1239. doi: 10.1007/s10461-019-02393-z.

29.

Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda.

Musiimenta A, Atukunda EC, Tumuhimbise W, Haberer JE.

AIDS Care. 2018 Aug;30(sup5):S89-S96. doi: 10.1080/09540121.2018.1510107. Epub 2019 Jan 9.

30.

The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda.

Campbell JI, Musiimenta A, Burns B, Natukunda S, Musinguzi N, Haberer JE, Eyal N.

AIDS Care. 2019 Jun;31(6):761-766. doi: 10.1080/09540121.2018.1556381. Epub 2018 Dec 9.

PMID:
30606037
31.

Screening for HIV and linkage to care in adolescents: insights from a systematic review of recent interventions in high- versus low- and middle-income settings.

Zanoni BC, Elliott RJ, Neilan AM, Haberer JE.

Adolesc Health Med Ther. 2018 Dec 4;9:211-235. doi: 10.2147/AHMT.S153204. eCollection 2018. Review.

32.

Biomarker-Measured Unhealthy Alcohol Use in Relation to CD4 Count Among Individuals Starting ART in Sub-Saharan Africa.

Magidson JF, Fatch R, Orrell C, Amanyire G, Haberer JE, Hahn JA; META team.

AIDS Behav. 2019 Jun;23(6):1656-1667. doi: 10.1007/s10461-018-2364-2.

33.

Barriers to Retention in Care are Overcome by Adolescent-Friendly Services for Adolescents Living with HIV in South Africa: A Qualitative Analysis.

Zanoni BC, Sibaya T, Cairns C, Haberer JE.

AIDS Behav. 2019 Apr;23(4):957-965. doi: 10.1007/s10461-018-2352-6.

PMID:
30535836
34.

Text Messages Sent to Household Tuberculosis Contacts in Kampala, Uganda: Process Evaluation.

Meyer AJ, Babirye D, Armstrong-Hough M, Mark D, Ayakaka I, Katamba A, Haberer JE, Davis JL.

JMIR Mhealth Uhealth. 2018 Nov 20;6(11):e10239. doi: 10.2196/10239.

35.

Feasibility, Acceptability, and Adoption of Digital Fingerprinting During Contact Investigation for Tuberculosis in Kampala, Uganda: A Parallel-Convergent Mixed-Methods Analysis.

White EB, Meyer AJ, Ggita JM, Babirye D, Mark D, Ayakaka I, Haberer JE, Katamba A, Armstrong-Hough M, Davis JL.

J Med Internet Res. 2018 Nov 15;20(11):e11541. doi: 10.2196/11541.

36.

Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study.

Muwonge TR, Ngure K, Katabira E, Mugo N, Kimemia G, Burns BFO, Musinguzi N, Bambia F, Baeten JM, Heffron R, Haberer JE; Partners Mobile Adherence to PrEP (PMAP) Team.

AIDS Behav. 2019 May;23(5):1267-1276. doi: 10.1007/s10461-018-2326-8.

PMID:
30406335
37.

Feasibility and Acceptability of Real-Time Antiretroviral Adherence Monitoring among Depressed Women Living with HIV in the Deep South of the US.

Stringer KL, Azuero A, Ott C, Psaros C, Jagielski CH, Safren SA, Haberer JE, Kempf MC.

AIDS Behav. 2019 May;23(5):1306-1314. doi: 10.1007/s10461-018-2322-z.

PMID:
30377982
38.

Contraceptive use following unintended pregnancy among Ugandan women living with HIV.

Jarolimova J, Kabakyenga J, Bennett K, Muyindike W, Kembabazi A, Martin JN, Hunt PW, Boum Y, Haberer JE, Bangsberg DR, Kaida A, Matthews LT.

PLoS One. 2018 Oct 25;13(10):e0206325. doi: 10.1371/journal.pone.0206325. eCollection 2018.

39.

Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy.

Bell KM, Haberer JE.

Curr HIV/AIDS Rep. 2018 Oct;15(5):388-396. doi: 10.1007/s11904-018-0413-0. Review.

40.

Advancing equitable global health research partnerships in Africa.

Boum Ii Y, Burns BF, Siedner M, Mburu Y, Bukusi E, Haberer JE.

BMJ Glob Health. 2018 Aug 23;3(4):e000868. doi: 10.1136/bmjgh-2018-000868. eCollection 2018. No abstract available.

41.

Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda.

Young CR, Kaida A, Kabakyenga J, Muyindike W, Musinguzi N, Martin JN, Hunt PW, Bangsberg DR, Haberer JE, Matthews LT.

PLoS One. 2018 Aug 27;13(8):e0202992. doi: 10.1371/journal.pone.0202992. eCollection 2018.

42.

Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships.

Pyra M, Brown ER, Haberer JE, Heffron R, Celum C, Bukusi EA, Asiimwe S, Katabira E, Mugo NR, Baeten JM; Partners Demonstration Project Team.

AIDS Behav. 2018 Nov;22(11):3718-3725. doi: 10.1007/s10461-018-2221-3.

43.

Comparison of short messaging service self-reported adherence with other adherence measures in a demonstration project of HIV preexposure prophylaxis in Kenya and Uganda.

Musinguzi N, Muwonge T, Ngure K, Katabira E, Mugo N, Burns BFO, Baeten JM, Heffron R, Haberer JE; Partners Mobile Adherence to PrEP (PMAP) Team.

AIDS. 2018 Sep 24;32(15):2237-2245. doi: 10.1097/QAD.0000000000001955.

44.

Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005-2013.

McCluskey SM, Lee GQ, Kamelian K, Kembabazi A, Musinguzi N, Bwana MB, Muzoora C, Haberer JE, Hunt PW, Martin JN, Boum Y 2nd, Bangsberg DR, Harrigan PR, Siedner MJ.

AIDS Patient Care STDS. 2018 Jul;32(7):257-264. doi: 10.1089/apc.2018.0020.

45.

CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies.

Chang JL, Lee SA, Tsai AC, Musinguzi N, Muzoora C, Bwana B, Boum Y 2nd, Haberer JE, Hunt PW, Martin J, Bangsberg DR, Kroetz DL, Siedner MJ.

AIDS Res Hum Retroviruses. 2018 Nov;34(11):982-992. doi: 10.1089/AID.2018.0062. Epub 2018 Aug 15.

46.

Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.

Chang JL, Tsai AC, Musinguzi N, Haberer JE, Boum Y, Muzoora C, Bwana M, Martin JN, Hunt PW, Bangsberg DR, Siedner MJ.

Ann Intern Med. 2018 Aug 7;169(3):146-155. doi: 10.7326/M17-2252. Epub 2018 Jun 26.

47.

Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere.

Campbell JI, Eyal N, Musiimenta A, Burns B, Natukunda S, Musinguzi N, Haberer JE.

AIDS Behav. 2018 Oct;22(10):3363-3372. doi: 10.1007/s10461-018-2200-8.

48.

Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis.

Pyra M, Anderson PL, Hendrix CW, Heffron R, Mugwanya K, Haberer JE, Thomas KK, Celum C, Donnell D, Marzinke MA, Bukusi EA, Mugo NR, Asiimwe S, Katabira E, Baeten JM; Partners Demonstration Study Team.

AIDS. 2018 Aug 24;32(13):1891-1898. doi: 10.1097/QAD.0000000000001922.

49.

Female Sex Workers Often Incorrectly Interpret HIV Self-Test Results in Uganda.

Ortblad KF, Musoke DK, Ngabirano T, Nakitende A, Haberer JE, McConnell M, Salomon JA, Bärnighausen T, Oldenburg CE.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):e42-e45. doi: 10.1097/QAI.0000000000001765. No abstract available.

50.

Acceptability and Feasibility of Real-Time Antiretroviral Therapy Adherence Interventions in Rural Uganda: Mixed-Method Pilot Randomized Controlled Trial.

Musiimenta A, Atukunda EC, Tumuhimbise W, Pisarski EE, Tam M, Wyatt MA, Ware NC, Haberer JE.

JMIR Mhealth Uhealth. 2018 May 17;6(5):e122. doi: 10.2196/mhealth.9031.

Supplemental Content

Loading ...
Support Center